USSTOCK.TODAY
Pre-Market
Log in Sign up
Company overview

What Does Natural Alternatives International (NAII) Do? — A Complete Guide to Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters

Updated August 14, 2026 · First published April 23, 2026

Natural Alternatives International (NAII) operates a contract manufacturing business for customized nutritional supplements along with a beta-alanine royalty program. When reviewing NAII's stock price and revenue, it is important to consider key customers' inventory adjustments, new orders, product development capabilities, and quality management together.

Briefs · earnings · signals, first Subscribe

🏢 What kind of company is Natural Alternatives International?

Natural Alternatives International is a U.S.-based nutritional supplement company that provides an integrated suite of services spanning formulation, manufacturing, testing, packaging, and warehousing for customized products. The business is built around a partnership-style operating model that adds science-based guidance and regulatory review support to customers' product development processes.

The core business is contract manufacturing of private-label nutritional supplements for consumer brands. The service offering runs from product formulation, ingredient sourcing, blending, quality testing, and finished-product packaging through to logistics, while royalties, licensing, and ingredient sales related to beta-alanine form a complementary revenue stream.

💰 How does Natural Alternatives International make money?

Business SegmentRevenue ShareDescription
Private-label contract manufacturingCoreFormulation, production, quality testing, packaging, and warehousing services for customized nutritional supplements

The revenue structure centers on contract manufacturing produced under customer brands, and order volume along with customers' inventory management policies affect utilization rates and revenue flows. Beta-alanine royalties and licensing provide a revenue stream distinct from the manufacturing business, contributing to diversification. In contract manufacturing, profitability is tied to management of ingredient procurement, production efficiency, quality control, and packaging costs. New customer wins and order recovery from existing customers are the key growth drivers, but changes in individual customer ordering patterns can translate into short-term earnings volatility.

📐 Natural Alternatives International market cap and company size

The market capitalization stands at $12.6M, while the employee headcount has not been publicly disclosed.

This company is a publicly listed entity that can be evaluated within the consumer staples sector based on its customized nutritional supplement production capabilities. The focus is on the combination of private-label contract manufacturing and ingredient royalties, and capital allocation is best assessed in terms of its impact on production capacity utilization, working capital management, and customer base expansion. When comparing against other packaged food companies, the analysis should distinguish differences in product development support and quality management systems rather than simple top-line size.

Natural Alternatives International outlook and stock price trends

In the near term, customer inventory adjustments, order timing, production capacity utilization, and ingredient costs can influence revenue and profitability. Order recovery from contract manufacturing customers and the addition of new customers can serve as drivers of improved utilization, while science-based formulation support and regulatory review capabilities can contribute to long-term order-book competitiveness. Beta-alanine royalties and licensing provide a revenue stream distinct from manufacturing demand, but this stream is also affected by customers' product launches and sales patterns. Shifts in consumer sentiment, ingredient procurement conditions, customer concentration, and the price negotiation environment are factors that can heighten the volatility of the outlook.

🎯 Key Growth Drivers
Expansion of customized nutritional supplement orders
Easing of customer inventory adjustments and recovery of production utilization
Growth in beta-alanine royalties and licensing

⚔️ Natural Alternatives International core strengths and risks

Integrated manufacturing and quality management capabilities and royalty-based complementary revenue are strengths, while fluctuations in customer orders and ingredient costs are the main risks.

💪 Core Strengths

Integrated manufacturing services
A connected suite spanning formulation through quality testing, packaging, and warehousing supports customers' product launch processes.
Science-based product support
Nutritional supplement design and regulatory review support provide a collaboration foundation that goes beyond simple production.
Revenue stream diversification
Beyond contract manufacturing, beta-alanine royalties and licensing offer a complementary revenue stream.

⚠️ Core Risks

Customer order fluctuations
Inventory adjustments or changes in order plans among key customers can affect facility utilization rates and revenue flows.
Ingredient and production costs
Changes in ingredient procurement conditions, packaging costs, and production efficiency can translate into profitability volatility.
Competition and pricing pressure
Competition within the nutritional supplement contract manufacturing market and the price negotiation environment can pressure new orders and margins.
Regulatory compliance burden
Ongoing management is required to keep pace with quality standards and regulatory changes for health-related products.
Here are the competitors and related (beneficiary) stocks of Natural Alternatives International.

The direct competitor lineup has been left empty. Among the candidates provided, BRLS, JVA, and COOT are related names that can be reviewed alongside the packaged food sector, but it is difficult to conclude that each of their business models is identical to customized nutritional supplement contract manufacturing. Accordingly, these stocks are best viewed from a related-stock perspective that compares consumer staple ingredients, food demand, and product distribution environments, rather than as direct competitors.

✅ Investor checkpoints for Natural Alternatives International

When reviewing Natural Alternatives International, it is more important to look at contract manufacturing customer order flows, production utilization, and ingredient business royalty flows together rather than the quarterly numbers in isolation. Because share price movements can be sensitive to customer inventory adjustments and order changes, a comprehensive review of customer base expansion and the maintenance of quality management capabilities is necessary.

CheckpointWhat to VerifyCurrent Status
📦 Order flowAssess the impact of key customers' inventory adjustments and new orders on contract manufacturing utilization.Watching for recovery
🧪 Ingredient businessReview the royalty and licensing revenue flow from the beta-alanine ingredient business.Maintaining complementary revenue
🏭 Production efficiencyExamine how ingredient procurement, quality management, and packaging costs affect profitability.Cost management required

Because contract manufacturing is affected by customers' inventory adjustments and order variations, facility utilization and revenue flows can be disrupted over short periods. Ingredient prices, packaging costs, quality management burdens, and changes in the regulatory environment can also weigh on profitability, and if new orders arrive later than expected, uncertainty around the pace of recovery can grow.

Natural Alternatives International is a company that operates both customized nutritional supplement contract manufacturing and beta-alanine ingredient royalties. Investment decisions should confirm the durability of customer orders, production utilization, the complementary effect of the ingredient business, and cost management flows in tandem, and careful monitoring is warranted given short-term volatility.

1-Year Price Performance
Analyst Consensus
No analyst coverage
Small-cap or newly listed stocks may not have valuation data collected.
52-Week Price Range
$2
Low $2 High $5
vs. low +1.01% vs. high -59.68%

⚔️ Natural Alternatives International core strengths and risks

Integrated manufacturing and quality management capabilities and royalty-based complementary revenue are strengths, while fluctuations in customer orders and ingredient costs are the main risks.

💪 Core Strengths

Integrated manufacturing services
A connected suite spanning formulation through quality testing, packaging, and warehousing supports customers' product launch processes.
Science-based product support
Nutritional supplement design and regulatory review support provide a collaboration foundation that goes beyond simple production.
Revenue stream diversification
Beyond contract manufacturing, beta-alanine royalties and licensing offer a complementary revenue stream.

⚠️ Core Risks

Customer order fluctuations
Inventory adjustments or changes in order plans among key customers can affect facility utilization rates and revenue flows.
Ingredient and production costs
Changes in ingredient procurement conditions, packaging costs, and production efficiency can translate into profitability volatility.
Competition and pricing pressure
Competition within the nutritional supplement contract manufacturing market and the price negotiation environment can pressure new orders and margins.
Regulatory compliance burden
Ongoing management is required to keep pace with quality standards and regulatory changes for health-related products.
Here are the competitors and related (beneficiary) stocks of Natural Alternatives International.

The direct competitor lineup has been left empty. Among the candidates provided, BRLS, JVA, and COOT are related names that can be reviewed alongside the packaged food sector, but it is difficult to conclude that each of their business models is identical to customized nutritional supplement contract manufacturing. Accordingly, these stocks are best viewed from a related-stock perspective that compares consumer staple ingredients, food demand, and product distribution environments, rather than as direct competitors.

Related stocks (beneficiaries)
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
BRLSBRLSBorealis Foods Inc$1.38+3.0%$29.6M---5302.44%-
JVAJVACoffee Holding Co Inc$3.43-3.4%$19.6M12.90.75.32%2.33%
COOTCOOTAustralian Oilseeds Holdings Limited$0.48-3.0%$22.3M-7.7--

✅ Investor checkpoints for Natural Alternatives International

When reviewing Natural Alternatives International, it is more important to look at contract manufacturing customer order flows, production utilization, and ingredient business royalty flows together rather than the quarterly numbers in isolation. Because share price movements can be sensitive to customer inventory adjustments and order changes, a comprehensive review of customer base expansion and the maintenance of quality management capabilities is necessary.

CheckpointWhat to VerifyCurrent Status
📦 Order flowAssess the impact of key customers' inventory adjustments and new orders on contract manufacturing utilization.Watching for recovery
🧪 Ingredient businessReview the royalty and licensing revenue flow from the beta-alanine ingredient business.Maintaining complementary revenue
🏭 Production efficiencyExamine how ingredient procurement, quality management, and packaging costs affect profitability.Cost management required

Because contract manufacturing is affected by customers' inventory adjustments and order variations, facility utilization and revenue flows can be disrupted over short periods. Ingredient prices, packaging costs, quality management burdens, and changes in the regulatory environment can also weigh on profitability, and if new orders arrive later than expected, uncertainty around the pace of recovery can grow.

Natural Alternatives International is a company that operates both customized nutritional supplement contract manufacturing and beta-alanine ingredient royalties. Investment decisions should confirm the durability of customer orders, production utilization, the complementary effect of the ingredient business, and cost management flows in tandem, and careful monitoring is warranted given short-term volatility.

Briefs · earnings · signals, first Subscribe
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →